Floatz logo

Prednisone

Diffuse Large B-Cell Lymphoma

Beth Israel Deaconess Medical CenterSmall moleculePhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
74/ 100
Competitive Position
73/ 100

Competitive context

252 Active assets in the Diffuse Large B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Vincristine Sulfate
National Cancer Institute (NCI)
Phase 2/3A
Melphalan
Ruijin Hospital
Phase 4BBB
Axicabtagene Ciloleucel
Ruijin Hospital
Phase 4BBB
Cyclosporin A
Fred Hutchinson Cancer Center
Phase 3BBB
Nivestim
Ruijin Hospital
Phase 3BBB

View all 50 →

Same molecule, other indications

Prednisone is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
74 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedActive
BBB
Indicative · Phase 4
74 / 100
View asset →
skin cancerActive
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →